These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7700920)

  • 1. Immunomagnetic CD8 depletion.
    Jansen J; Hanks S; Akard L; Martin M; Ash R; Thompson J; English D
    Prog Clin Biol Res; 1994; 389():551-6. PubMed ID: 7700920
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Jansen J; Hanks S; Akard L; Martin M; Thompson J; Chang Q; Ash R; Garrett P; Figg F; English D
    Bone Marrow Transplant; 1995 Feb; 15(2):271-8. PubMed ID: 7773217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract]   [Full Text] [Related]  

  • 7. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of an immunomagnetic separation procedure to deplete V alpha beta-positive T cells from marrow for use in partially mismatched related donor (PMRD) transplantation.
    Lamb L; Metherell J; Lee C; Brouillette M; Thompson J; Brown S; Henslee-Downey PJ; Gee A
    Prog Clin Biol Res; 1994; 389():541-50. PubMed ID: 7700919
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
    Jansen J; Hanks S; English D; Karaffa R; Akard L
    Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
    Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
    Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.
    Jansen J; Hanks S; Akard LP; Thompson JM; Burns S; Chang Q; English D; Garrett P
    Bone Marrow Transplant; 1996 Mar; 17(3):377-82. PubMed ID: 8704690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
    Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
    Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
    [No Abstract]   [Full Text] [Related]  

  • 15. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.